Taken together, our results establish C. elegans as a powerful model to understand how chromatin changes result in aberrant cell fates, and identify the JNK pathway as a potential drug target for treatment of H3.3K27M-positive gliomas. The gene discussed is MAPK8; the disease is central nervous system cancer.